April 12th, 2013
Biodesix Closes Series D Financing
April 11th, 2013
Biodesix Announces Agreement with Bruker Daltonics to Support Mass Spectrometry-based Diagnostic Tests
April 2nd, 2013
Peer-Reviewed Study Confirms VeriStrat® Test from Biodesix Provides Useful Information for Physicians in Managing Patients with Lung Cancer
March 18th, 2013
Biodesix’ Heinrich Roder Presents at 2013 Biomarker Summit
February 20th, 2013
VeriStrat® Provides Oncologists with More Information to Personalize Therapy for Elderly Patients With Lung Cancer
September 6th, 2012
VeriStrat® Test Predicts Differential Treatment Benefit between Chemotherapy and Targeted Therapy for Lung Cancer Patients
August 29th, 2012
Biodesix Closes Series D Financing
August 23rd, 2012
Biodesix Announces New VeriStrat® Data to be Presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology
July 17th, 2012
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
June 27th, 2012
Biodesix’ Proteomic Analysis of Innovative Immunotherapy Clinical Trial in Pancreas Cancer presented at European Society of Medical Oncology’s (ESMO) World Congress on Gastrointestinal Cancer